The Colorado Supreme Court has ordered Children's Hospital Colorado to resume providing medical treatments including puberty blockers and hormone therapy to minors, despite the hospital's concerns that continuing such care could jeopardize its federal funding and institutional viability.
The 5-2 ruling, issued Monday, forces the state's largest provider of gender-affirming care for young people to restart treatments it had suspended in January 2026. The hospital halted the medical interventions after the U.S. Department of Health and Human Services opened an investigation into its treatments, following conflicts between the Trump administration and advocates over transgender health care for children.
The Legal Challenge
Four transgender girls, ages 10 to 17, sued the hospital through their parents, claiming violations of the state's antidiscrimination law. The plaintiffs alleged the hospital refused treatment based on their gender identity and their disability, gender dysphoria. The girls cited fears about undergoing puberty and developing male traits, along with mental health concerns including depression and suicidal ideation.
In the majority opinion, Justice William Wood III wrote that "the actual immediate and irreparable harm to petitioners outweighs the speculative harm CHC may face if the federal government further acts against it." The court determined the suspension violated state antidiscrimination law.
Institutional Concerns
In a pointed dissent, Justice Brian Boatright argued the hospital's decision was not discriminatory but rather "driven by the direct threat to the viability of the entire hospital." The dissent highlights the tension between state mandates and federal oversight that institutions now face.
The hospital's TRUE Center is one of the largest gender-affirming care programs in the country and the only comprehensive care center in the Rocky Mountain region, according to the lawsuit. Children's Hospital Colorado said it is reviewing the court ruling and considering its next steps. The hospital previously stated it would continue providing mental health treatment for minors and medical treatment for patients aged 18 to 21.
Federal Investigation
The HHS investigation was launched after Health and Human Services Secretary Robert F. Kennedy Jr. issued a declaration calling treatments like puberty blockers, hormone therapy and surgeries unsafe and ineffective for children and adolescents experiencing gender dysphoria. This federal position created the compliance dilemma that led to the hospital's initial suspension of services.
An Oregon-based federal judge ruled in March 2026 for Colorado and 20 other states that Kennedy's declaration went too far. A Kansas judge also sided with transgender minors in a ruling last week, creating a complex legal landscape where state courts are compelling actions that federal authorities have questioned.
Why This Matters:
This ruling places a major medical institution in an untenable position between conflicting government mandates. The hospital faces potential loss of federal funding—which sustains operations serving all patients—if it complies with the state court order. The case exemplifies how judicial activism at the state level can force private institutions to choose between legal compliance and institutional survival. It also demonstrates the costs of regulatory uncertainty: a hospital that serves thousands of children across multiple specialties now faces existential risk over one controversial program. The dissent's emphasis on institutional viability versus the majority's focus on individual claims reflects a fundamental tension in how courts balance competing interests when government entities at different levels pursue contradictory policies.